LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: Astrocytic Slc4a4 regulates blood-brain barrier integrity in healthy and stroke brains via a CCL2-CCR2 pathway and NO dysregulation.

    Ye, Qi / Jo, Juyeon / Wang, Chih-Yen / Oh, Heavin / Zhan, Jiangshan / Choy, Tiffany J / Kim, Kyoung In / D'Alessandro, Angelo / Reshetnyak, Yana K / Jung, Sung Yun / Chen, Zheng / Marrelli, Sean P / Lee, Hyun Kyoung

    Cell reports

    2024  Volume 43, Issue 5, Page(s) 114193

    Abstract: Astrocytes play vital roles in blood-brain barrier (BBB) maintenance, yet how they support BBB integrity under normal or pathological conditions remains poorly defined. Recent evidence suggests that ion homeostasis is a cellular mechanism important for ... ...

    Abstract Astrocytes play vital roles in blood-brain barrier (BBB) maintenance, yet how they support BBB integrity under normal or pathological conditions remains poorly defined. Recent evidence suggests that ion homeostasis is a cellular mechanism important for BBB integrity. In the current study, we investigated the function of an astrocyte-specific pH regulator, Slc4a4, in BBB maintenance and repair. We show that astrocytic Slc4a4 is required for normal astrocyte morphological complexity and BBB function. Multi-omics analyses identified increased astrocytic secretion of CCL2 coupled with dysregulated arginine-NO metabolism after Slc4a4 deletion. Using a model of ischemic stroke, we found that loss of Slc4a4 exacerbates BBB disruption, which was rescued by pharmacological or genetic inhibition of the CCL2-CCR2 pathway in vivo. Together, our study identifies the astrocytic Slc4a4-CCL2 and endothelial CCR2 axis as a mechanism controlling BBB integrity and repair, while providing insights for a therapeutic approach against BBB-related CNS disorders.
    Language English
    Publishing date 2024-05-05
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2024.114193
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article: Astrocytic Slc4a4 regulates blood-brain barrier integrity in healthy and stroke brains via a NO-CCL2-CCR2 pathway.

    Ye, Qi / Jo, Juyeon / Wang, Chih-Yen / Oh, Heavin / Choy, Tiffany J / Kim, Kyoungin / D'Alessandro, Angelo / Reshetnyak, Yana K / Jung, Sung Yun / Chen, Zheng / Marrelli, Sean P / Lee, Hyun Kyoung

    bioRxiv : the preprint server for biology

    2023  

    Abstract: Astrocytes play vital roles in blood-brain barrier (BBB) maintenance, yet how they support BBB integrity under normal or pathological conditions remains poorly defined. Recent evidence suggests pH homeostasis is a new cellular mechanism important for BBB ...

    Abstract Astrocytes play vital roles in blood-brain barrier (BBB) maintenance, yet how they support BBB integrity under normal or pathological conditions remains poorly defined. Recent evidence suggests pH homeostasis is a new cellular mechanism important for BBB integrity. In the current study, we investigated the function of an astrocyte-specific pH regulator, Slc4a4, in BBB maintenance and repair. We show that astrocytic Slc4a4 is required for normal astrocyte morphological complexity and BBB function. Multi-omics analyses identified increased astrocytic secretion of CCL2 coupled with dysregulated arginine-NO metabolism after Slc4a4 deletion. Using a model of ischemic stroke, we found that loss of Slc4a4 exacerbates BBB disruption and reactive gliosis, which were both rescued by pharmacological or genetic inhibition of the NO-CCL2 pathway
    Language English
    Publishing date 2023-04-03
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.04.03.535167
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  3. Article ; Online: Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS.

    Schulze, Christopher J / Seamon, Kyle J / Zhao, Yulei / Yang, Yu C / Cregg, Jim / Kim, Dongsung / Tomlinson, Aidan / Choy, Tiffany J / Wang, Zhican / Sang, Ben / Pourfarjam, Yasin / Lucas, Jessica / Cuevas-Navarro, Antonio / Ayala-Santos, Carlos / Vides, Alberto / Li, Chuanchuan / Marquez, Abby / Zhong, Mengqi / Vemulapalli, Vidyasiri /
    Weller, Caroline / Gould, Andrea / Whalen, Daniel M / Salvador, Anthony / Milin, Anthony / Saldajeno-Concar, Mae / Dinglasan, Nuntana / Chen, Anqi / Evans, Jim / Knox, John E / Koltun, Elena S / Singh, Mallika / Nichols, Robert / Wildes, David / Gill, Adrian L / Smith, Jacqueline A M / Lito, Piro

    Science (New York, N.Y.)

    2023  Volume 381, Issue 6659, Page(s) 794–799

    Abstract: The discovery of small-molecule inhibitors requires suitable binding pockets on protein surfaces. Proteins that lack this feature are considered undruggable and require innovative strategies for therapeutic targeting. ...

    Abstract The discovery of small-molecule inhibitors requires suitable binding pockets on protein surfaces. Proteins that lack this feature are considered undruggable and require innovative strategies for therapeutic targeting.
    MeSH term(s) Humans ; Biological Products/chemistry ; Biological Products/pharmacology ; Biological Products/therapeutic use ; Cysteine/chemistry ; Cysteine/genetics ; Molecular Chaperones/chemistry ; Molecular Chaperones/metabolism ; Proto-Oncogene Proteins p21(ras)/antagonists & inhibitors ; Proto-Oncogene Proteins p21(ras)/chemistry ; Proto-Oncogene Proteins p21(ras)/genetics ; Signal Transduction ; Cyclophilin A/chemistry ; Cyclophilin A/metabolism ; Immunophilins/chemistry ; Immunophilins/metabolism ; Neoplasms/drug therapy ; Neoplasms/genetics
    Chemical Substances Biological Products ; Cysteine (K848JZ4886) ; KRAS protein, human ; Molecular Chaperones ; Proto-Oncogene Proteins p21(ras) (EC 3.6.5.2) ; Cyclophilin A (EC 5.2.1.-) ; Immunophilins (EC 5.2.1.8)
    Language English
    Publishing date 2023-08-17
    Publishing country United States
    Document type Journal Article
    ZDB-ID 128410-1
    ISSN 1095-9203 ; 0036-8075
    ISSN (online) 1095-9203
    ISSN 0036-8075
    DOI 10.1126/science.adg9652
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 27: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)
    Zs.MG 77: Show issues

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  4. Article ; Online: Allosteric Inhibition of SHP2 Stimulates Antitumor Immunity by Transforming the Immunosuppressive Environment.

    Quintana, Elsa / Schulze, Christopher J / Myers, Darienne R / Choy, Tiffany J / Mordec, Kasia / Wildes, David / Shifrin, Nataliya Tobvis / Belwafa, Amira / Koltun, Elena S / Gill, Adrian L / Singh, Mallika / Kelsey, Stephen / Goldsmith, Mark A / Nichols, Robert / Smith, Jacqueline A M

    Cancer research

    2020  Volume 80, Issue 13, Page(s) 2889–2902

    Abstract: The protein tyrosine phosphatase SHP2 binds to phosphorylated signaling motifs on regulatory immunoreceptors including PD-1, but its functional role in tumor immunity is unclear. Using preclinical models, we show that RMC-4550, an allosteric inhibitor of ...

    Abstract The protein tyrosine phosphatase SHP2 binds to phosphorylated signaling motifs on regulatory immunoreceptors including PD-1, but its functional role in tumor immunity is unclear. Using preclinical models, we show that RMC-4550, an allosteric inhibitor of SHP2, induces antitumor immunity, with effects equivalent to or greater than those resulting from checkpoint blockade. In the tumor microenvironment, inhibition of SHP2 modulated T-cell infiltrates similar to checkpoint blockade. In addition, RMC-4550 drove direct, selective depletion of protumorigenic M2 macrophages via attenuation of CSF1 receptor signaling and increased M1 macrophages via a mechanism independent of CD8
    MeSH term(s) Allosteric Regulation ; Animals ; Apoptosis ; Breast Neoplasms/immunology ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Breast Neoplasms/prevention & control ; Cell Proliferation ; Female ; Humans ; Immunosuppressive Agents/pharmacology ; Macrophages/immunology ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Protein Tyrosine Phosphatase, Non-Receptor Type 11/antagonists & inhibitors ; Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics ; Protein Tyrosine Phosphatase, Non-Receptor Type 11/metabolism ; Signal Transduction ; Tumor Cells, Cultured ; Tumor Microenvironment/immunology ; Xenograft Model Antitumor Assays
    Chemical Substances Immunosuppressive Agents ; PTPN11 protein, human (EC 3.1.3.48) ; Protein Tyrosine Phosphatase, Non-Receptor Type 11 (EC 3.1.3.48)
    Language English
    Publishing date 2020-04-29
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1432-1
    ISSN 1538-7445 ; 0008-5472
    ISSN (online) 1538-7445
    ISSN 0008-5472
    DOI 10.1158/0008-5472.CAN-19-3038
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Uh III Zs.135/5: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  5. Article ; Online: Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity.

    Myers, Darienne R / Abram, Clare L / Wildes, David / Belwafa, Amira / Welsh, Alia M N / Schulze, Christopher J / Choy, Tiffany J / Nguyen, Tram / Omaque, Neil / Hu, Yongmei / Singh, Mallika / Hansen, Rich / Goldsmith, Mark A / Quintana, Elsa / Smith, Jacqueline A M / Lowell, Clifford A

    Frontiers in immunology

    2020  Volume 11, Page(s) 576310

    Abstract: Shp1, encoded by the ... ...

    Abstract Shp1, encoded by the gene
    MeSH term(s) Adaptive Immunity ; Adenocarcinoma/enzymology ; Adenocarcinoma/immunology ; Adenocarcinoma/pathology ; Adenocarcinoma/therapy ; Animals ; Antigens, Differentiation/metabolism ; Breast Neoplasms/enzymology ; Breast Neoplasms/immunology ; Breast Neoplasms/pathology ; Breast Neoplasms/therapy ; Colonic Neoplasms/enzymology ; Colonic Neoplasms/immunology ; Colonic Neoplasms/pathology ; Colonic Neoplasms/therapy ; Female ; Humans ; Immunity, Innate ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/metabolism ; Melanoma, Experimental/enzymology ; Melanoma, Experimental/immunology ; Melanoma, Experimental/pathology ; Melanoma, Experimental/therapy ; Mice, Inbred C57BL ; Mice, Knockout ; Phagocytosis ; Protein Tyrosine Phosphatase, Non-Receptor Type 6/deficiency ; Protein Tyrosine Phosphatase, Non-Receptor Type 6/genetics ; Receptors, Immunologic/metabolism ; Signal Transduction ; Skin Neoplasms/enzymology ; Skin Neoplasms/immunology ; Skin Neoplasms/pathology ; Skin Neoplasms/therapy ; THP-1 Cells ; Tumor Burden ; Tumor Microenvironment ; Tumor-Associated Macrophages/enzymology ; Tumor-Associated Macrophages/immunology
    Chemical Substances Antigens, Differentiation ; Ptpns1 protein, mouse ; Receptors, Immunologic ; SIRPA protein, human ; PTPN6 protein, human (EC 3.1.3.48) ; Protein Tyrosine Phosphatase, Non-Receptor Type 6 (EC 3.1.3.48) ; Ptpn6 protein, mouse (EC 3.1.3.48)
    Language English
    Publishing date 2020-09-29
    Publishing country Switzerland
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2020.576310
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top